atenolol and avapro

atenolol has been researched along with avapro in 49 studies

Research

Studies (49)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (4.08)	18.2507
2000's	38 (77.55)	29.6817
2010's	9 (18.37)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Haworth, D; Hoglund, C; Kassler-Taub, K; Kerwin, L; Martin, A; Masson, C; Osbakken, M; Simon, T; Stumpe, KO	1
Brown, MJ	1
Hatzizacharias, AN; Krespi, PG; Kyriakidis, MK; Makris, TK; Stavroulakis, GA; Triposkiadis, FK; Tsoukala, CG; Votteas, VV	1
Edner, M; Hägg, A; Held, C; Kahan, T; Lind, L; Malmqvist, K; Müller-Brunotte, R; Nyström, F; Ohman, KP; Osbakken, MD; Ostergern, J	1
Hägg, A; Kahan, T; Karlsson, J; Kurland, L; Lind, L; Malmqvist, K; Melhus, H; Nyström, F; Ohman, KP	1
Hägg, A; Kahan, T; Lind, L; Millgård, J; von zur Mühlen, B	1
Park, JB; Pu, Q; Schiffrin, EL	1
Hägg, A; Kahan, T; Karlsson, J; Kurland, L; Lind, L; Malmqvist, K; Melhus, H; Nyström, F; Ohman, P	2
Schiffrin, EL	1
Rapi, J	1
Kahan, T; Malmqvist, K; Nyström, F; Ohman, KP	1
Hallberg, P; Kahan, T; Karlsson, J; Kurland, L; Lind, L; Malmqvist, K; Melhus, H; Nyström, F; Ohman, KP	1
Bergfeldt, L; Edner, M; Kahan, T; Malmqvist, K	2
Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F	1
Karpov, IuA	1
Hallberg, P; Kahan, T; Karlsson, J; Kurland, L; Lind, L; Malmqvist, K; Melhus, H; Michaëlsson, K; Nyström, F; Ohman, KP	1
Hallberg, P; Kahan, T; Kurland, L; Liljedahl, U; Lind, L; Malmqvist, K; Melhus, H; Michaëlsson, K; Nyström, F; Ohman, KP; Syvänen, AC	1
Kahan, T; Lind, L; Malmqvist, K; Nyström, F; Ohman, KP	1
Kahan, T; Karlsson, J; Kurland, L; Liljedahl, U; Lind, L; Malmqvist, K; Melhus, H; Syvänen, AC	1
Billberger, K; Hallberg, P; Kahan, T; Karlsson, J; Kurland, L; Liljedahl, U; Lind, L; Malmqvist, K; Melhus, H; Michaelsson, K; Nyström, F; Ohman, KP; Syvänen, AC	1
Delles, C; Klingbeil, AU; Kolloch, RE; Krekler, M; Ludwig, M; Schmieder, RE; Schneider, MP; Stumpe, KO	2
Hallberg, P; Kahan, T; Karlsson, J; Kurland, L; Liljedahl, U; Lind, L; Malmqvist, K; Melhus, H; Michaëlsson, K; Nyström, F; Ohman, KP; Syvänen, AC	1
Berglund, L; Kahan, T; Kurland, L; Liljedahl, U; Lind, L; Syvänen, AC	1
Kahan, T; Kurland, L; Liljedahl, U; Lind, L; Malmqvist, K; Melhus, H; Syvänen, AC	1
Edner, M; Kahan, T; Malmqvist, K; Müller-Brunotte, R	1
Ivannikova, OA; Kaliuzhin, VV; Makushkin, EV; Malakhovich, EV; Pushnikova, EIu; Stepacheva, TA; Tepliakov, AT; Zenevich, MV	1
Dimopoulos-Xicki, L; Haas, M	1
Anwar, A; Bonvini, RF; Hendiri, T	1
Jiang, YY; Shen, FM; Su, DF; Xie, HH; Zhang, XF	1
Edner, M; Kahan, T; Malmqvist, K; Müller-Brunotte, R; Ring, M	1
Bella, JN	1
Held, C; Kahan, T; Malmqvist, K; Mörtsell, D	1
Díez, J; Edner, M; González, A; Kahan, T; López, B; Malmqvist, K; Müller-Brunotte, R	1
Aubert, JF; Bouzourene, K; Hayoz, D; Mazzolai, L; Nussberger, J; Pellegrin, M	1
Hallberg, P; Hashemi, N; Kahan, T; Kurland, L; Liljedahl, U; Lind, L; Melhus, H; Syvänen, AC	1
Arnlöv, J; Kahan, T; Liljedahl, S; Lind, L	1
Galantine, V; Gosse, P; Lacraz, A; Rubin, S	1
Jekell, A; Kahan, T; Malmqvist, K; Mörtsell, D; Wallén, NH	1
Chadha, R; Haneef, J	1
Atkins, E; Bennett, A; Burke, M; Chalmers, J; Chou, M; Chow, CK; Dehbi, HM; Hillis, G; Hilmer, S; Krum, H; Neal, B; Nelson, M; Patel, A; Peiris, D; Reid, CM; Rodgers, A; Rogers, K; Salam, A; Thakkar, J; Thom, S; Usherwood, T; Vo, K; Webster, R; Woodward, M	1

Reviews

6 review(s) available for atenolol and avapro

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Irbesartan treatment in hypertension. Hospital medicine (London, England : 1998), 1998, Volume: 59, Issue:10 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Enalapril; Humans; Hypertension; Irbesartan; Losartan; Renin-Angiotensin System; Tetrazoles	1998
Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers. The Canadian journal of cardiology, 2002, Volume: 18 Suppl A Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Atenolol; Biphenyl Compounds; Cilazapril; Humans; Hypertension; Irbesartan; Losartan; Perindopril; Tetrazoles	2002
[Irbesartan: a new possibility in the treatment of hypertension]. Orvosi hetilap, 2002, May-26, Volume: 143, Issue:21 Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Controlled Clinical Trials as Topic; Drug Administration Schedule; Enalapril; Half-Life; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan	2002
[Clinical hypertensiology: analysis of trials completed in 2001-2002]. Kardiologiia, 2002, Volume: 42, Issue:10 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Complications; Diastole; Diuretics; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Losartan; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Risk; Risk Factors; Stroke; Systole; Tetrazoles; Time Factors	2002
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. Lancet (London, England), 2017, 03-11, Volume: 389, Issue:10073 Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome	2017

Trials

31 trial(s) available for atenolol and avapro

Article	Year
Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertension. Blood pressure, 1998, Volume: 7, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome	1998
Fibrinolytic/hemostatic variables in arterial hypertension: response to treatment with irbesartan or atenolol. American journal of hypertension, 2000, Volume: 13, Issue:7 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Coagulation; Endothelium, Vascular; Female; Fibrinolysis; Hemostasis; Humans; Hypertension; Irbesartan; Lipids; Male; Middle Aged; Tetrazoles	2000
Regression of left ventricular hypertrophy in human hypertension with irbesartan. Journal of hypertension, 2001, Volume: 19, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Safety; Tetrazoles; Vascular Resistance	2001
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients. Journal of hypertension, 2001, Volume: 19, Issue:10 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Female; Forecasting; Humans; Hypertension; Irbesartan; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Tetrazoles; Treatment Outcome	2001
Treatment with irbesartan or atenolol improves endothelial function in essential hypertension. Journal of hypertension, 2001, Volume: 19, Issue:10 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Double-Blind Method; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Irbesartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Regional Blood Flow; Tetrazoles; Vasodilation	2001
Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. Journal of hypertension, 2002, Volume: 20, Issue:1 Topics: Acetylcholine; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Arteries; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Endothelium, Vascular; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Nitroprusside; Receptors, Angiotensin; Sensitivity and Specificity; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome; Vascular Resistance	2002
Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol ( Journal of hypertension, 2002, Volume: 20, Issue:4 Topics: Aged; Alleles; Angiotensin Receptor Antagonists; Angiotensinogen; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; Sweden; Tetrazoles	2002
Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. American journal of hypertension, 2002, Volume: 15, Issue:5 Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Base Sequence; Biphenyl Compounds; Blood Pressure; Cytochrome P-450 CYP11B2; Cytosine; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Tetrazoles; Thymine; Treatment Outcome	2002
Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study. Journal of hypertension, 2002, Volume: 20, Issue:8 Topics: Adult; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Prognosis; Sweden; Tetrazoles	2002
The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. Journal of hypertension, 2002, Volume: 20, Issue:10 Topics: Adult; Aged; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Atenolol; Biphenyl Compounds; Blood Pressure; Cytochrome P-450 CYP2C9; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Genotype; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Predictive Value of Tests; Randomized Controlled Trials as Topic; Sweden; Systole; Tetrazoles; Treatment Outcome	2002
Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA). The American journal of cardiology, 2002, Nov-15, Volume: 90, Issue:10 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Echocardiography; Electrocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome	2002
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:6 Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed	2002
B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Journal of hypertension, 2003, Volume: 21, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Double-Blind Method; Female; Genotype; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Organ Size; Polymorphism, Genetic; Receptor, Bradykinin B2; Sweden; Tetrazoles	2003
Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy. BMC cardiovascular disorders, 2003, Sep-18, Volume: 3 Topics: Adipocytes; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Double-Blind Method; Female; Genotype; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Leucyl Aminopeptidase; Male; Middle Aged; Polymorphism, Genetic; Remission Induction; Single-Blind Method; Tetrazoles	2003
Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). Journal of cardiovascular pharmacology, 2003, Volume: 42, Issue:6 Topics: Adult; Aged; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Renin; Renin-Angiotensin System; Tetrazoles	2003
Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. American journal of hypertension, 2004, Volume: 17, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Female; Genotype; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Polymorphism, Single Nucleotide; Renin-Angiotensin System; Tetrazoles; Treatment Outcome	2004
Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). Clinical cardiology, 2004, Volume: 27, Issue:3 Topics: Antihypertensive Agents; Atenolol; Biphenyl Compounds; Double-Blind Method; Female; Genotype; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Linear Models; Male; Polymorphism, Genetic; Sweden; Tetrazoles; Transforming Growth Factor beta; Treatment Outcome	2004
Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 44, Issue:1 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Double-Blind Method; Echocardiography; Electrocardiography; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Tetrazoles	2004
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). Clinical cardiology, 2004, Volume: 27, Issue:5 Topics: Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Endothelin-1; Female; Genotype; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Polymorphism, Genetic; Sex Factors; Tetrazoles; Treatment Outcome	2004
Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment. Journal of hypertension, 2004, Volume: 22, Issue:12 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Antihypertensive Agents; Apolipoproteins B; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Echocardiography; Female; Genotype; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Multivariate Analysis; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Polymorphism, Single Nucleotide; Predictive Value of Tests; Receptors, Adrenergic, beta-2; Tetrazoles	2004
Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy. Journal of hypertension, 2005, Volume: 23, Issue:3 Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Diastole; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Stroke Volume; Tetrazoles; Ventricular Function, Left	2005
[Antihypertensive and antiischemic effectiveness and safety of the AT1-receptor blocker irbesartranin arterial hypertension in patients with prior myocardial infarction]. Klinicheskaia meditsina, 2004, Volume: 82, Issue:12 Topics: Administration, Oral; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Coronary Angiography; Coronary Circulation; Drug Therapy, Combination; Echocardiography; Follow-Up Studies; Heart Ventricles; Humans; Hypertension; Irbesartan; Male; Myocardial Infarction; Prospective Studies; Radionuclide Ventriculography; Tetrazoles; Treatment Outcome; Ventricular Function, Left	2004
Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation American journal of hypertension, 2006, Volume: 19, Issue:9 Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Flow Velocity; Blood Pressure; Confounding Factors, Epidemiologic; Diastole; Double-Blind Method; Echocardiography, Doppler; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Stroke Volume; Sweden; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Function, Left	2006
Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. Journal of internal medicine, 2007, Volume: 261, Issue:5 Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Carotid Artery, Common; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome; Tunica Intima	2007
Cardiac repolarization and its relation to ventricular geometry and rate in reverse remodelling during antihypertensive therapy with irbesartan or atenolol: results from the SILVHIA study. Journal of human hypertension, 2007, Volume: 21, Issue:12 Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Diastole; Double-Blind Method; Electrocardiography; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Potassium; Single-Blind Method; Sodium; Supine Position; Systole; Tetrazoles; Ventricular Dysfunction, Left	2007
Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). Journal of hypertension, 2007, Volume: 25, Issue:9 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cardiomyopathies; Collagen Type I; Diastole; Double-Blind Method; Female; Fibrosis; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles	2007
Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2008, Volume: 9, Issue:1 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles	2008
The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol ( American journal of hypertension, 2008, Volume: 21, Issue:7 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Female; Genotype; Homozygote; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Sweden; Tetrazoles; Treatment Outcome	2008
The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy: results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SI Echocardiography (Mount Kisco, N.Y.), 2009, Volume: 26, Issue:7 Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Comorbidity; Echocardiography, Doppler; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Image Interpretation, Computer-Assisted; Irbesartan; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Reproducibility of Results; Sensitivity and Specificity; Sweden; Tetrazoles; Treatment Outcome	2009
Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: results from the SILVHIA study. Journal of cardiovascular pharmacology, 2013, Volume: 62, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Arteries; Atenolol; Biomarkers; Biphenyl Compounds; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Inflammation Mediators; Irbesartan; Male; Middle Aged; Tetrazoles; Vascular Resistance; Vascular Stiffness	2013
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. Lancet (London, England), 2017, 03-11, Volume: 389, Issue:10073 Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome	2017

Other Studies

13 other study(ies) available for atenolol and avapro

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment. BMC cardiovascular disorders, 2004, Sep-28, Volume: 4, Issue:1 Topics: Analysis of Variance; Antihypertensive Agents; Apolipoproteins B; Atenolol; Biphenyl Compounds; Female; Genotype; Humans; Hypertension; Irbesartan; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Receptors, LDL; Systole; Tetrazoles	2004
[Therapeutic implications of ACE-gene polymorphism]. Wiener medizinische Wochenschrift (1946), 2005, Volume: 155, Issue:3-4 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Diabetic Nephropathies; Genetic Variation; Genotype; Humans; Hypertension; Irbesartan; Kidney Diseases; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prognosis; Tetrazoles; Time Factors	2005
Sinus arrest and moderate hyperkalemia. Annales de cardiologie et d'angeiologie, 2006, Volume: 55, Issue:3 Topics: Antihypertensive Agents; Arrhythmia, Sinus; Atenolol; Biphenyl Compounds; Bradycardia; Depression, Chemical; Diltiazem; Female; Heart Arrest; Heart Rate; Humans; Hyperkalemia; Irbesartan; Middle Aged; Tetrazoles	2006
Blood pressure variability, baroreflex sensitivity and organ damage in spontaneously hypertensive rats treated with various antihypertensive drugs. European journal of pharmacology, 2006, Aug-14, Volume: 543, Issue:1-3 Topics: Animals; Antihypertensive Agents; Aorta; Atenolol; Baroreflex; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Kidney Diseases; Male; Nifedipine; Rats; Rats, Inbred SHR; Tetrazoles	2006
Treatment of diastolic dysfunction in hypertensive left ventricular hypertrophy. American journal of hypertension, 2006, Volume: 19, Issue:9 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Flow Velocity; Blood Pressure; Diastole; Echocardiography, Doppler; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Stroke Volume; Tetrazoles; Ventricular Function, Left	2006
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:5 Topics: Amides; Amlodipine; Animals; Antihypertensive Agents; Apolipoproteins E; Atenolol; Atherosclerosis; Biphenyl Compounds; Blood Pressure; Cholesterol; Disease Models, Animal; Disease Progression; Female; Fumarates; Heart Rate; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin; Renin-Angiotensin System; Tetrazoles	2008
Malignant hypertension and interferon-beta: a case report. Journal of human hypertension, 2014, Volume: 28, Issue:5 Topics: Adult; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Bisoprolol; Female; Humans; Hypertension, Malignant; Immunologic Factors; Interferon-beta; Irbesartan; Multiple Sclerosis; Ramipril; Renin-Angiotensin System; Tetrazoles	2014
Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach. AAPS PharmSciTech, 2017, Volume: 18, Issue:6 Topics: Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Biphenyl Compounds; Crystallization; Drug Combinations; Female; Hydrochlorothiazide; Irbesartan; Rats; Rats, Wistar; Solubility; Telmisartan; Tetrazoles	2017